Neurocrine Bioscience buy Guggenheim
Start price
02.05.24
/
50%
€131.25
Target price
02.05.25
€158.42
Performance (%)
-0.27%
Price
17.05.24
€130.90
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by -0.27%. This prediction currently runs until 02.05.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | 3.152% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Guggenheim from $164.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat